StockWatch
·

Carysil Ltd Q1 FY27 Results

CARYSILQ1 FY27 Results
Filing
Result:Good· Market: SurgedMargin expansionBroad basedRecord quarter

Beat/Miss: Inline · Outlook: Optimistic · Guidance: Maintained

MetricValueQ4 FY26Q1 FY26
Revenue262.14 Cr12.2%15.5%
Total Income266.11 Cr11.7%16.6%
Expenditure223.99 Cr9.5%13.2%
PBT42.12 Cr24.5%38.9%
Net Profit32.05 Cr17.1%39.9%
OPM20.37%1.10pp1.05pp
NPM12.04%0.55pp2.00pp
EPS11.0516.1%37.6%
View full financials

Revenue growth (+15.5% YoY) merely at the floor of Carysil's own 15-20% guidance while EBITDA margin expanded to 20.37% and adjusted PAT rose a clean 39.9% YoY with no one-offs, making this a healthy but not standout consumer/manufacturing print.

CARYSIL · Q1 FY27 · THE VERDICT

Margins soar above guidance; export logistics drag the growth story

Carysil posted a 120-bps EBITDA beat and 40% domestic growth, yet guided unchanged. The reason: quartz volume is held back by container delays, and capex execution becomes the gating factor for next-phase growth.

14 Aug 2026 · 6 min read
Revenue

₹264.8 Cr

+16.5% YoY, +12.2% QoQ

EBITDA margin

21.2%

+175 bps YoY · beats 18-20% band by 120 bps

PAT

₹31.4 Cr

+37.7% YoY · PAT margin 11.9%

Domestic revenue

₹56 Cr

+39.8% YoY · 21% of revenue

The beats don't explain the sell-off

On the surface, this is a blowout: revenue ahead of the 15% guidance lower band, EBITDA margin 120 bps above the upper band, PAT growth at 38%. Yet the stock fell 4.4% on day 1 (Aug 10, 2026) and held lower through day 3. The market's read is harder: the beats are real, but they mask a production bottleneck that guidance now acknowledges. Quartz volume, Carysil's core business at 51% of revenue, grew only 6% despite orders at an all-time peak. The culprit: container logistics disruption held back exports. Factories are running 88–94% utilization. Capex of ₹80–90 Cr over FY27, due March 2027, is no longer nice-to-have—it is the constraint on whether this company can grow beyond 15–20%.

Management's key claims vs. what holds up

India domestic sales up to almost 40% Y-o-Y

₹56 Cr domestic, up from ~₹40 Cr prior year = 39.8% growth

Supported

Tracking towards upper band of 18–20% EBITDA margin

Q1 achieved 21.2%, exceeds band by 120 bps

Supported

Quartz volume growing; order book at peak utilization

Quartz +6% volume only; logistics blamed for dispatch delays; actual utilization 88–94%

Overstated on momentum

US discount rollback already 90% done; will boost margins

Rollback came in June (Q1 end); Lowe's USD 5–6M display cost-sharing offset benefit

Supported, partially offset

Stainless steel emerging as major growth driver

Steel +16% volume to 49.4K units; capacity doubled to 250K units, now at 94% utilization

Supported

What changed on this call

Three structural shifts reframe the Q1 read. First, domestic acceleration materialized. India domestic segment grew 40% (₹56 Cr), all four product categories rose 28–60%, and Carysil Blue D2C brand is sold out across India on a 60-day backlog. This wasn't a guess from prior calls—it's now real. Second, UK builder channel opened for the first time. New customers Bodel, Barwick, JJO, and others are now buying; the builder segment was untapped until now. Management expects UK sales uptick from Q2 onward, with a Manchester showroom and premium surfaces/appliances launch planned for Q3. Third, the capex rationale shifted from incremental (100K quartz units) to bulk infrastructure (250K units, with path to 500K). This is demand-driven, not balance-sheet housekeeping. The order book (Lowe's, IKEA, Home Depot, Hafele, Amazon) is so large that Carysil is funding for headroom, not just near-term needs.

Where the margin beat came from

The EBITDA margin expanded 175 bps YoY to 21.2%, with three drivers. First, US discount rollback (90% complete by June): Lowe's deal pricing now reflects full value after pandemic discounting. Second, operating leverage: Revenue +16.5% on a flatter cost base as factories optimize. Third, product mix: Higher-ASP items (premium quartz, steel, faucets) gained share. Management guided 18–20% EBITDA margin for the full year and 5-year horizon; the 21.2% beat suggests upside potential if logistics normalize and capex ramps smoothly. But the stock's caution is worth noting: a beat on margins can coexist with execution risk on volume.

The bull-bear ledger
  • Margin beat by 120 bps; demonstrates operating leverage and mix shift working

  • Domestic +40% across all four categories; India growth story now real, not guidance

  • Faucets +43%, fastest-growing category; new export ramp initiated

  • UK builder segment opened; new channels (Bodel, Barwick, JJO) entering

  • Clear 5-year vision to ₹1,000 Cr backed by large order book and funded capex

  • Quartz volume only +6% YoY despite all-time high order peak; logistics dragging

  • Factory capacity at stress (88–94% utilization); capex March 2027 deadline is hard constraint

  • Guidance maintained, not raised, despite 120-bps margin beat; management not confident on sustain

  • UK market described as 'modest' and 'cautiously optimistic'; new builder channel unproven

  • Faucet exports 97% India; export ramp still early-stage, quality certification underway

  • Surfaces fabrication (CNC tech) not yet live; March FY27 deadline tight

How the street is positioned

The stock fell 4.4% on day 1 (Aug 10, 2026) and held lower at −3.6% by day 3. This is a classic 'beat on earnings, sell on outlook' move. The market's reasoning: margin beats don't justify a higher valuation if they're peaking and growth is capped by logistics/capex. At ₹1,179.8, the stock is 7.6% below its all-time high and up 61% from the 52-week low (₹732.1). Volume is trending higher, RSI sits at neutral 53.8, and price is above all key moving averages (SMA20, SMA50, SMA200), suggesting technical support remains. Ownership is stable: FII at 1.63% (+0.04pp QoQ), DII at 11.91% (+0.18pp), promoter at 41.33% (flat). No bulk insider selling near the highs, which is reassuring. The sell-off appears tactical (short-term de-risking on execution concerns) rather than structural.

Risks, ranked by how much they should concern a holder

Capex execution delay (March 2027 deadline at risk)

High

Factories at 88–94% utilization; capex is the only path to scale. Delay caps growth to sub-15% and handcuffs new segments (surfaces, appliances, faucets exports). Management said 'my factory has to run 7 days a week'—this signals urgency but also fragility.

Quartz volume weakness despite peak orders (logistics drag)

High

Core business (51% revenue) grew only 6% despite all-time high order peak. Container delays are temporary, but if they persist beyond Q2 or recur, the 15% volume guidance is at risk. Shipment timing volatility can swing Q-on-Q profit.

Margin sustainability at 21%+ (not in guidance band)

Medium

US discount rollback (90% done June) is a one-time reset. Operating leverage helped this Q, but capex depreciation will offset. Expect margins to normalize to 18–20% band as capex comes on stream. Investors extrapolating 21% are overstating 2027–2028 profit.

UK market softness; builder channel unproven (9-month track record pending)

Medium

UK described as 'modest,' and new builder customers (Bodel, JJO, Barwick) only entered Q1. No proof they will scale. If UK stays flat and builder ramp is slow, geographic diversification thesis weakens.

New category execution (surfaces, appliances, faucets export)

Medium

Surfaces segment CNC fabrication not yet live (target March FY27). Faucets 97% India still; export ramp quality-stage. Appliances 53% in-house. These are growth pillars in guidance, but unproven at scale. Execution risk on all three.

Customer concentration (Lowe's, IKEA, Home Depot key accounts)

Medium

Export ₹111 Cr concentrated among few global retailers. Lowe's deal with USD 5–6M display cost-sharing is structurally tied. Loss of a key account would materially impact export growth.

What to watch next
  • 1 · Q2 quartz volume rebound (will container delays clear?)

    Core business grew only 6% in Q1 due to logistics. If Q2 shipments normalize and volume pops to 12–15% growth, the capex thesis holds. If delays persist into Q2, capex urgency becomes visible and guidance risk rises.

  • 2 · Capex quarterly milestones and on-track evidence (March 2027 deadline)

    Management needs to show progress each quarter: quartz capacity to 250K units, steel to 150K, surfaces CNC live. Any slip signals execution risk and would likely trigger a −5% to −10% sell-off.

  • 3 · Domestic festive season response (Sep–Nov 2026 celebrity roadshow & 90-day campaign)

    India domestic is the upside surprise (+40%). Can it sustain, or normalize as base effects kick in? The roadshow and 34 new store openings (Q2) should show early traction by Q2 earnings. If domestic momentum fades, the 15% guidance comes under pressure.

Carysil's Q1 is a step-change quarter on execution—margin beat, domestic acceleration, new UK channels—but not yet a step-change in confidence. The market's caution (−4.4% day 1) is warranted: growth is bottlenecked by logistics (quartz +6%) and capex execution (March 2027 deadline). Guidance maintained, not raised, despite the 120-bps margin beat, signals that management knows margins will normalize and growth is capped unless capex lands on time.

The number to track from here: Q2 quartz volume growth. If it bounces to 12–15% as logistics normalize, capex thesis holds and the stock re-rates. If it stays in single digits, watch for capex delay signals in Q2 and Q3 earnings. At ₹1,179.8, the stock prices in execution risk; reward comes only if capex and domestic momentum prove real.

Informational and educational content only. Not investment advice.

Carysil Ltd (CARYSIL) Q1 FY27 Results, Transcript & Analysis — StockWatch